Drug
Ganaplacide
Ganaplacide: highest development phase Phase 1, developed by Novartis. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ganaplacide NCT05084651 | Phase 1 | Malaria |
| Ganaplacide NCT05330273 | Phase 1 | Malaria |
Latest
No recent events.
Follow Ganaplacide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.